[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vera Therapeutics Inc Cl A (VERA)

Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Vera Therapeutics Inc Cl A 2000 SIERRA POINT PARKWAY SUITE 1200 BRISBANE CA 94005 USA

www.veratx.com Employees: 249 P: 650-770-0077

Sector:

Medical

Description:

Vera Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Vera Therapeutics Inc. is based in SOUTH SAN FRANCISCO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 2,279,353
Enterprise Value, $K 1,999,463
Shares Outstanding, K 72,063
Float, K 60,605
% Float 84.10%
Short Interest, K 15,282
Short Float 21.21%
Days to Cover 9.42
Short Volume Ratio 0.59
% of Insider Shareholders 15.90%
% of Institutional Shareholders 99.21%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -299,610 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -109,470 K
EBIT, $ -415,760 K
EBITDA, $ -420,420 K

Growth:

1-Year Return 47.25%
3-Year Return 76.61%
5-Year Return 98.81%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.52 on 08/10/26
Next Earnings Date 11/04/26
Earnings Per Share ttm -5.86
EPS Growth vs. Prev Qtr 10.06%
EPS Growth vs. Prev Year -26.67%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payable Date 01/29/96
Dividend Payout Ratio 0.00%

VERA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -84.13%
Return-on-Assets % -66.79%
Profit Margin % 0.00%
Debt/Equity 0.18
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 5.59
Book Value/Share 5.66
Interest Coverage -38.79
60-Month Beta 0.92
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.